FDA to lift warnings on menopause hormone therapy, potentially boosting access - The Washington Post
Health
The FDA is asking drug manufacturers to remove black box warnings on hormone replacement therapy for menopause, which could make it easier for women to access the treatment.
Updated November 10, 202? [+43 chars]
Leave A Comment
Comments
No comments yet. Be the first to comment!
